United Services Automobile Association cut its holdings in Natus Medical Inc (NASDAQ:BABY) by 51.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 151,404 shares of the medical equipment provider’s stock after selling 161,080 shares during the period. United Services Automobile Association owned 0.45% of Natus Medical worth $5,223,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Sei Investments Co. lifted its holdings in Natus Medical by 46.3% in the second quarter. Sei Investments Co. now owns 4,669 shares of the medical equipment provider’s stock valued at $161,000 after acquiring an additional 1,478 shares during the last quarter. Legal & General Group Plc lifted its stake in Natus Medical by 2.2% during the second quarter. Legal & General Group Plc now owns 70,721 shares of the medical equipment provider’s stock worth $2,460,000 after purchasing an additional 1,508 shares in the last quarter. Great West Life Assurance Co. Can lifted its stake in Natus Medical by 4.3% during the first quarter. Great West Life Assurance Co. Can now owns 43,407 shares of the medical equipment provider’s stock worth $1,459,000 after purchasing an additional 1,773 shares in the last quarter. MetLife Investment Advisors LLC lifted its stake in Natus Medical by 14.2% during the second quarter. MetLife Investment Advisors LLC now owns 15,157 shares of the medical equipment provider’s stock worth $523,000 after purchasing an additional 1,889 shares in the last quarter. Finally, LPL Financial LLC lifted its stake in Natus Medical by 23.1% during the first quarter. LPL Financial LLC now owns 12,986 shares of the medical equipment provider’s stock worth $437,000 after purchasing an additional 2,433 shares in the last quarter. Hedge funds and other institutional investors own 96.88% of the company’s stock.
A number of research analysts have commented on the company. BidaskClub upgraded Natus Medical from a “hold” rating to a “buy” rating in a research note on Thursday, August 2nd. Zacks Investment Research upgraded Natus Medical from a “sell” rating to a “hold” rating in a research note on Friday, August 10th. Finally, ValuEngine upgraded Natus Medical from a “sell” rating to a “hold” rating in a research note on Saturday, July 28th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Natus Medical presently has an average rating of “Hold” and a consensus price target of $44.33.
NASDAQ:BABY opened at $32.01 on Friday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.19 and a current ratio of 2.99. Natus Medical Inc has a 52 week low of $28.00 and a 52 week high of $43.60. The firm has a market cap of $1.19 billion, a price-to-earnings ratio of 22.08 and a beta of 0.59.
Natus Medical (NASDAQ:BABY) last released its quarterly earnings results on Wednesday, July 25th. The medical equipment provider reported $0.35 EPS for the quarter, topping analysts’ consensus estimates of $0.26 by $0.09. The company had revenue of $130.70 million for the quarter, compared to analysts’ expectations of $130.60 million. Natus Medical had a positive return on equity of 11.18% and a negative net margin of 4.16%. The firm’s revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.34 earnings per share. As a group, analysts anticipate that Natus Medical Inc will post 1.55 EPS for the current fiscal year.
In other news, insider Jonathan Kennedy sold 47,600 shares of the stock in a transaction on Thursday, August 30th. The stock was sold at an average price of $36.85, for a total value of $1,754,060.00. Following the sale, the insider now directly owns 161,628 shares in the company, valued at $5,955,991.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Ken Ludlum sold 8,000 shares of the stock in a transaction on Thursday, August 2nd. The shares were sold at an average price of $36.89, for a total value of $295,120.00. Following the completion of the sale, the director now owns 98,957 shares in the company, valued at $3,650,523.73. The disclosure for this sale can be found here. Over the last quarter, insiders sold 77,540 shares of company stock worth $2,804,615. Insiders own 5.50% of the company’s stock.
About Natus Medical
Natus Medical Incorporated provides newborn care, neurology, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders.
Further Reading: Day Trading – Risk Worth the Reward?
Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.